Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-12-05

Clinical Trial Update: Bioequivalence Study to Compare Brexpiprazole 4 mg Film Coated Tablets Versus RXULTI 4 mg Film Coated Tablet (Brexpiprazole) [Phase 1]

View source ↗

Summary

Phase 1 bioequivalence study comparing Brexpiprazole 4 mg film-coated tablets to RXULTI 4 mg tablets has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RXULTI (brexpiprazole)
  • brexpiprazole (brexpiprazole)

Snippet

Sponsor: Humanis Saglık Anonim Sirketi | Conditions: Schizophrenia | Phase 1 | Status: COMPLETED